CN101716008B - Vinegar beverage with function of protecting and nourishing liver - Google Patents
Vinegar beverage with function of protecting and nourishing liver Download PDFInfo
- Publication number
- CN101716008B CN101716008B CN2009102312280A CN200910231228A CN101716008B CN 101716008 B CN101716008 B CN 101716008B CN 2009102312280 A CN2009102312280 A CN 2009102312280A CN 200910231228 A CN200910231228 A CN 200910231228A CN 101716008 B CN101716008 B CN 101716008B
- Authority
- CN
- China
- Prior art keywords
- extract
- vinegar
- protecting
- liver
- xylo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000052 vinegar Substances 0.000 title claims abstract description 49
- 235000021419 vinegar Nutrition 0.000 title claims abstract description 49
- 210000004185 liver Anatomy 0.000 title claims abstract description 32
- 235000013361 beverage Nutrition 0.000 title claims abstract description 25
- 239000000284 extract Substances 0.000 claims abstract description 45
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 241000196324 Embryophyta Species 0.000 claims abstract description 16
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 15
- 235000018958 Gardenia augusta Nutrition 0.000 claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 14
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 13
- 235000013305 food Nutrition 0.000 claims abstract description 13
- 229940013618 stevioside Drugs 0.000 claims abstract description 13
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000019202 steviosides Nutrition 0.000 claims abstract description 13
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 11
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 10
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 10
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 10
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 9
- 240000006432 Carica papaya Species 0.000 claims description 11
- 235000009467 Carica papaya Nutrition 0.000 claims description 11
- 230000006870 function Effects 0.000 abstract description 8
- 235000013399 edible fruits Nutrition 0.000 abstract description 7
- 239000000203 mixture Substances 0.000 abstract description 7
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 abstract description 4
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 241000186000 Bifidobacterium Species 0.000 abstract description 3
- 210000004051 gastric juice Anatomy 0.000 abstract description 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- 230000036528 appetite Effects 0.000 abstract description 2
- 235000019789 appetite Nutrition 0.000 abstract description 2
- 210000004204 blood vessel Anatomy 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract 2
- 240000000425 Chaenomeles speciosa Species 0.000 abstract 1
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 210000004243 sweat Anatomy 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 21
- 239000002994 raw material Substances 0.000 description 12
- 230000001954 sterilising effect Effects 0.000 description 12
- 238000004659 sterilization and disinfection Methods 0.000 description 11
- 239000012467 final product Substances 0.000 description 10
- 238000012856 packing Methods 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 240000004307 Citrus medica Species 0.000 description 5
- 235000001938 Citrus medica Nutrition 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 229960004793 sucrose Drugs 0.000 description 3
- WUYQEGNOQLRQAQ-CQSZACIVSA-N (+)-pronuciferine Chemical compound C([C@H]1N(C)CCC=2C=C(C(=C3C=21)OC)OC)C13C=CC(=O)C=C1 WUYQEGNOQLRQAQ-CQSZACIVSA-N 0.000 description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 229940116229 borneol Drugs 0.000 description 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 2
- 230000002279 cholagogic effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 229960003487 xylose Drugs 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- WUYQEGNOQLRQAQ-UHFFFAOYSA-N (+)-pronuciferine Natural products C1=2C3=C(OC)C(OC)=CC=2CCN(C)C1CC13C=CC(=O)C=C1 WUYQEGNOQLRQAQ-UHFFFAOYSA-N 0.000 description 1
- LGQKSQQRKHFMLI-SJYYZXOBSA-N (2s,3r,4s,5r)-2-[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)OC1 LGQKSQQRKHFMLI-SJYYZXOBSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- JCSJTDYCNQHPRJ-UHFFFAOYSA-N 20-hydroxyecdysone 2,3-acetonide Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(OC2C(C(O)C(O)OC2)O)OC1 JCSJTDYCNQHPRJ-UHFFFAOYSA-N 0.000 description 1
- LGQKSQQRKHFMLI-UHFFFAOYSA-N 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(O)OC1 LGQKSQQRKHFMLI-UHFFFAOYSA-N 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 235000006264 Asimina triloba Nutrition 0.000 description 1
- 241000189115 Catananche Species 0.000 description 1
- 241001507936 Chaenomeles Species 0.000 description 1
- 241000723353 Chrysanthemum Species 0.000 description 1
- 241000333459 Citrus x tangelo Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- SQNRKWHRVIAKLP-UHFFFAOYSA-N D-xylobiose Natural products O=CC(O)C(O)C(CO)OC1OCC(O)C(O)C1O SQNRKWHRVIAKLP-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- XJMPAUZQVRGFRE-SCHFUKFYSA-N Gardenoside Natural products O=C(OC)C=1[C@H]2[C@H]([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)[C@@](O)(CO)C=C2 XJMPAUZQVRGFRE-SCHFUKFYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 206010019695 Hepatic neoplasm Diseases 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 241000209477 Nymphaeaceae Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000123069 Ocyurus chrysurus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- JCTYWRARKVGOBK-CQSZACIVSA-N Remerin Chemical compound C12=C3C4=CC=CC=C4C[C@H]1N(C)CCC2=CC1=C3OCO1 JCTYWRARKVGOBK-CQSZACIVSA-N 0.000 description 1
- JCTYWRARKVGOBK-UHFFFAOYSA-N Roemerine Natural products C12=C3C4=CC=CC=C4CC1N(C)CCC2=CC1=C3OCO1 JCTYWRARKVGOBK-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- JVZHSOSUTPAVII-UHFFFAOYSA-N Xylotetraose Natural products OCC(OC1OCC(OC2OCC(OC3OCC(O)C(O)C3O)C(O)C2O)C(O)C1O)C(O)C(O)C=O JVZHSOSUTPAVII-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- JCSJTDYCNQHPRJ-FDVJSPBESA-N beta-D-Xylp-(1->4)-beta-D-Xylp-(1->4)-D-Xylp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)C(O)OC2)O)OC1 JCSJTDYCNQHPRJ-FDVJSPBESA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- -1 borneol acetic acid esters Chemical class 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- XJMPAUZQVRGFRE-AYDWLWLASA-N methyl (1s,4as,7s,7as)-7-hydroxy-7-(hydroxymethyl)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,7a-dihydro-1h-cyclopenta[c]pyran-4-carboxylate Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1[C@](C=C2)(O)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XJMPAUZQVRGFRE-AYDWLWLASA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 238000012946 outsourcing Methods 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229930001545 pronuciferine Natural products 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 238000009394 selective breeding Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- ABKNGTPZXRUSOI-UHFFFAOYSA-N xylotriose Natural products OCC(OC1OCC(OC2OCC(O)C(O)C2O)C(O)C1O)C(O)C(O)C=O ABKNGTPZXRUSOI-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a vinegar beverage with function of protecting and nourishing liver, which consists of the following compositions in percentage by weight: 0.1 to 30 percent of xylo-oligosaccharide, 15 to 20 percent of vinegar, 6 to 10 percent of a food and drug homologous liver protection and nourishing plant active composition, 0.005 to 0.02 percent of stevioside and the balance being water. The food and drug homologous liver protection and nourishing plant active composition consists of a lotus leaf extract, a finger citron extract, a cape jasmine fruit extract, a chrysanthemum extract, a common floweringquince fruit extract and an exocarpium citri leiocarpae extract. The vinegar beverage has pure taste, pleasant sweetness and sourness, and excellent lustrousness, smell and appearance, has the health-care functions of removing fatigue, enhancing appetite, constraining sweat, dispersing damp, strengthening the bactericidal function of gastric juice, softening blood vessels, preventing cardiovascular disease and the like of vinegar and also has the characteristics of preventing decayed tooth, having low energy, selecting bifidobacterium proliferation at high efficiency and inhibiting the growth of other harmful flora of the xylo-oligosaccharide. The added liver protecting and nourishing composition directly plays a role in protecting human liver.
Description
Technical field
The present invention relates to a kind of vinegar beverage with function of protecting and nourishing liver.
Background technology
Vinegar is a kind of international important flavouring, and China common people just have the tradition of making vinegar and vinegar since ancient times.Vinegar at first is as flavouring, has higher nutritive value, in the cooking, uses very extensively.Vinegar also is one of five kinds of basic flavors, but can not become flavor separately, must share just with other each flavor to work, and it is the main seasoning raw material that constitutes multiple compound flavor.
Vinegar is a kind of flavouring, is again Chinese medicine commonly used simply.Its taste is bitter, and is warm in nature, goes into liver, stomach warp, has convergence, pain relieving, Li Shui, detumescence, desinsection, helps digestion, controls insect bite and injure disinfective action.Put down in writing according to Compendium of Material Medica: vinegar can be subsided a swelling pain, aproll gas, pathogenic toxin killing, reason at medicine.
Also often be added with the xylo-oligosaccharide of Oilgosaccharkdes high selectivity in the vinegar beverage of prior art; For example: publication number is the patent of a kind of xylo-oligosaccharide fruit vinegar of CN1532275; Be to be primary raw material, add compositions such as xylo-oligosaccharide, red date and licorice and be made with rice vinegar and fruit juice; And publication number is a kind of auxotype vinegar beverage and production method that is rich in the xylo-oligosaccharide Oilgosaccharkdes of CN 1672597N, and its principal character all is the fast breeding to the intestinal beneficial bacterium crowd of xylo-oligosaccharide, and to the inhibitory action of other harmful bacterium.But discovery is added with the xylo-oligosaccharide vinegar beverage of the direct protection liver function of food and medicine consangunity protecting and nourishing liver property plant.
Summary of the invention
To above-mentioned prior art, the invention provides a kind of sugar-free function of protecting and nourishing liver property vinegar beverage, be exactly to add functional sweetener in the vinegar beverage specifically---the protecting and nourishing liver active components of plants of xylo-oligosaccharide and food and medicine consangunity.
The present invention realizes through following technical scheme:
A kind of vinegar beverage with function of protecting and nourishing liver, form by following components in weight percentage: xylo-oligosaccharide 0.1～30%, vinegar 15～20%, food and medicine consangunity protecting and nourishing liver active components of plants 6～10%, stevioside 0.005～0.02%, surplus is a water.
Preferably, form by following components in weight percentage: xylo-oligosaccharide 7～14%, vinegar 15～20%, food and medicine consangunity protecting and nourishing liver active components of plants 6～10%, stevioside 0.005～0.02%, surplus is a water.
Said vinegar is brewage process production, meets relevant national standard, its acidity >=3.5g/100ml.
Said food and medicine consangunity protecting and nourishing liver active components of plants is a kind of in Lotus Leafextract, Fructus Citri Sarcodactylis extract, capejasmine extract, chrysanthemum extract, papaya extractives, the orange peel extract or their mixture.
During preparation, each raw material is mixed, stir, packing, high-temperature short-time sterilization gets final product.
Said various food and medicine consangunity protecting and nourishing liver active components of plants is outsourcing gained (can purchase in Xuancheng City hundred careless plant industry and trade Co., Ltd), and its specification is a water: the ratio extract of plant butt (weight ratio)=10: 1.Because the preparation technology of each plant extracts is processes well known, and on the market product is arranged, present patent application repeats no more.
The food and medicine consangunity protecting and nourishing liver active components of plants that the present invention adopted is the Lotus Leafextract in the material of 87 kinds of integration of drinking and medicinal herbs of Chinese name republic regulation; Fructus Citri Sarcodactylis extract, capejasmine extract, chrysanthemum extract; Papaya extractives; In the orange peel extract one or more have no side effect, and its effect is following:
Cape jasmine is the dry mature fruit of madder wort.Fructus gardeniae is widely distributed in that south is all economizes, and its main pharmacological has cholagogic, antibacterial, analgesia, anticonvulsion etc.The someone thinks at present, and the cyclenes terpene gardenoside in the cape jasmine is that cholagogic protects the liver main component.
Buddha's hand is the fruit of rutaceae Buddha's hand (Citrus medica L.var.sarcodactylis Swingle).Flavor is hot, little hardship, and is warm in nature.Can liver soothing and depression relief, regulate the flow of vital energy with in, reduce phlegm.Huang Ling etc. have observed the Buddha's hand polysaccharide to experimental mouse transplantability liver tumour HAC
2zInhibitory action, and compare with endoxan, find that the Buddha's hand polysaccharide is to HAC
2zGood inhibitory effect is arranged.
Pawpaw, rosaceae chaenomeles plant.Its fruit can be made preserved fruit; Hyoscine again can dredging the channel, and expelling pathogenic wind and promoting blood circulation has strong, excited, analgesia, puts down liver and spleen, the usefulness of removing dampness and relaxing myospasm.
Orange peel (Pericarpium Citri Reticulatae) is the pericarp of orange, cuts open 3～4 limbs more, and base portion links to each other, or is irregular fragment, thick about 1mm.Outer surface yellowly or rufous have fine wrinkle and circular little concave point, and the inner surface yellow-white is coarse, is spongy, very easily observe circle concave point greatly and closely, and base portion is residual to have channels and collaterals.Matter is soft, not frangible.Flavor is hot and little hardship is warm in nature, goes into spleen, lung channel." book on Chinese herbal medicine through hundred kinds of records ": the tangelo entire body is all fragrant, and the hot carnic acid of skin, be the liver and gall ventilation medicine also.So all liver-qi depressions, it is silly to restrain crafty spleen soil, all can be it.
Chrysanthemum (Flos Chrysanthemi), perennial catananche is the famous and precious ornamental flower of cultivating through long-term artificial selection, also claims the skill chrysanthemum, kind has reached over thousands of kind.Contain chrysanthemum glucoside, the fast cry of certain animals of gland, amino acid, stachydrine, choline, flavonoids, vitamin A appearance material, vitamin B1; Contain volatile oil, be mainly chrysanthemum ketone, borneol, borneol acetic acid esters etc. in the oil.Flavor is hot, and is sweet, hardship, cold nature.Return lung, Liver Channel; The ability dispelling wind and heat from the body is clear liver and improved vision, flat liver-yang, detoxifcation.
Lotus leaf is the dried leaves of nymphaeaceae plant lotus Nelumbo nucifera Gaertn..All produce the greater part, the medicinal material whole nation.Summer in 6～September, Qiu Erji gathered, and shone to seven, most probably dried, removed petiole, was folded in half into semicircle or fan-shaped, dried, and put aeration-drying place, and is mothproof.Summer is also with bright leaf or nascent tender.Lotus leaf contains nuciferine (Roemerine), miltanthin (Pronuciferine) and Nuciferine multiple alkaloid and vitamin Cs such as (Nuciferine).Bitter is hot little puckery, cool in nature, the thoughts of returning home, liver, spleen.
Said xylo-oligosaccharide is claimed wood oligose again, is to combine and the compound sugar of formation by 2-7 D-wood sugar and β-(1,4) wood sugar glycosidic bond, and be main active ingredient wherein with xylobiose, xylotriose, Xylotetrose; Outward appearance is milky or pale yellow powder, has good hear resistance and acid resistance; Sugariness is about 40% of sucrose, and its sweet taste is pure, with sucrose seemingly, but the part substituting saccharose uses as sweetener; Xylo-oligosaccharide is identical substantially with glucose to the influence of water activity, can be used as NMF and in food, uses; Its viscosity is very low, raises and decline rapidly with temperature, handles in the interpolation of various forms product, seems very convenient.Xylo-oligosaccharide is difficult to decomposed by the human consumption enzyme system; Saliva, gastric juice, pancreatic juice and intestinal fluid etc. all almost can not decompose xylo-oligosaccharide; Its energy value is approximately zero; Can in low-energy food, play a role, satisfy those to greatest extent and like sweets to worry that again the person's of getting fat requirement also can supply diabetes patient, adiposis patient and hyperglycemia patient edible.In addition, xylo-oligosaccharide has the function of improving the stool proterties, has increased the moisture in the stool behind the absorption xylo-oligosaccharide, can change the form of stool, thereby prevent the appearance of constipation; And xylo-oligosaccharide is the minimum compound sugar of Bifidobacterium propagation effective dose in the promotion enteron aisle of finding at present.
Vinegar beverage of the present invention adopts ultra high temperature short time sterilization because of it, good preservation the original local flavor of product, its pure taste, sour-sweet pleasant, color and luster, smell and figure are all good; The elimination of existing vinegar is tired, improve a poor appetite, the arrest sweating clearing damp; Strengthen health-care effects such as gastric juice sterilizing ability, softening blood vessel, prevention cardiovascular and cerebrovascular diseases; The anti-caries of xylo-oligosaccharide, low in calories, high efficiency selected propagation Bifidobacterium are arranged again, suppress the characteristic of other pernicious bacteria growth.In addition, the protecting and nourishing liver composition of interpolation will directly play a protective role to the human liver.
The specific embodiment
Below in conjunction with embodiment the present invention is further described:
A kind of vinegar beverage of embodiment 1 preparation
Prescription is: xylo-oligosaccharide 100g, vinegar 200g, capejasmine extract 80g, stevioside 0.5g, water 619.5g.
The preparation method is: each raw material mixed, stirs, and every 10-20ml packing, high-temperature short-time sterilization gets final product.
A kind of vinegar beverage of embodiment 2 preparations
Prescription is: xylo-oligosaccharide 100g, vinegar 200g, capejasmine extract 40g, Lotus Leafextract 25, orange peel extract 15, stevioside 0.5g, water 619.5g.
The preparation method is: each raw material mixed, stirs, and every 10-20ml packing, high-temperature short-time sterilization gets final product.
A kind of vinegar beverage of embodiment 3 preparations
Prescription is: xylo-oligosaccharide 80g, vinegar 180g, papaya extractives 40g, Fructus Citri Sarcodactylis extract 25, capejasmine extract 15, stevioside 0.56g, water 659.44g.
The preparation method is: each raw material mixed, stirs, and every 10-20ml packing, high-temperature short-time sterilization gets final product.
A kind of vinegar beverage of embodiment 4 preparations
Prescription is: xylo-oligosaccharide 6g, vinegar 200g, capejasmine extract 45g, Lotus Leafextract 20, orange peel extract 15, stevioside 0.9g, water 713.1g.
The preparation method is: each raw material mixed, stirs, and every bottle of 250-500ml packing, high-temperature short-time sterilization gets final product.
A kind of vinegar beverage of embodiment 5 preparations
Prescription is: xylo-oligosaccharide 4g, vinegar 150g, papaya extractives 50g, orange peel extract 35, stevioside 1.1g, water 759.9g.
The preparation method is: each raw material mixed, stirs, and every bottle of 250-500ml packing, high-temperature short-time sterilization gets final product.
A kind of vinegar beverage of embodiment 6 preparations
Prescription is: xylo-oligosaccharide 3g, vinegar 160g, papaya extractives 60g, capejasmine extract 10g, orange peel extract 10g, stevioside 1.15g, water 755.85g.
The preparation method is: each raw material mixed, stirs, and every bottle of 250-500ml packing, high-temperature short-time sterilization gets final product.
A kind of vinegar beverage of embodiment 7 preparations
Prescription is: xylo-oligosaccharide 120g, vinegar 180g, Lotus Leafextract 20g, Fructus Citri Sarcodactylis extract 20g, papaya extractives 20g, stevioside 0.8g, water 639.2g.
The preparation method is: each raw material mixed, stirs, and every 10-20ml packing, high-temperature short-time sterilization gets final product.
A kind of vinegar beverage of embodiment 8 preparations
Prescription is: xylo-oligosaccharide 100g, vinegar 178g, Fructus Citri Sarcodactylis extract 32g, capejasmine extract 25g, orange peel extract 38g, stevioside 0.5g, water 626.5g.
The preparation method is: each raw material mixed, stirs, and every 10-20ml packing, high-temperature short-time sterilization gets final product.
A kind of vinegar beverage of embodiment 9 preparations
Prescription is: xylo-oligosaccharide 80g, vinegar 165g, Fructus Citri Sarcodactylis extract 20g, capejasmine extract 18g, chrysanthemum extract 20g, papaya extractives 30g, stevioside 0.85g, water 666.15g.
The preparation method is: each raw material mixed, stirs, and every 10-20ml packing, high-temperature short-time sterilization gets final product.
Used Lotus Leafextract, Fructus Citri Sarcodactylis extract, capejasmine extract, chrysanthemum extract, papaya extractives, orange peel extract are all purchased in Xuancheng City hundred careless plant industry and trade Co., Ltds among the above embodiment, and its specification is a water: the ratio extract of plant butt (weight ratio)=10: 1.
Said beverage functional evaluation:
Part zoopery result is to carbon tetrachloride (CCl
4) cause the inhibitory action of mouse liver injury: get (20 ± 2g) totally 400 of SPF level female mices; Be divided into 20 groups at random; Every group 20, will be by the concentration of this drinks preparation, the stomach of per os filling once a day gives; If three groups of basic, normal, high dosage, dosage design are respectively 0.2,0.3,0.4g/kg.Normal control group and carbon tetrachloride control group give equivalent distilled water.In testing the 31st day with each treated animal fasting overnight 14 hours, CCl
4Control group is organized dose groups gives 0.15% (v/v) through lumbar injection CCl with each
4Oil solution 0.15ml/10g, the normal control group gives equivalent commercially available salad oil.Give CCl
4Put to death animal after 24 hours, blood sampling is measured glutamic-pyruvic transaminase (ALT), glutamic-oxalacetic transaminease (AST) in the serum.Experimental result shows, CCl
4Control group A LT and AST value obviously raise, each dose groups serum alt and AST and CCl
4The apparent in view reduction of control group, difference has utmost point conspicuousness.And mouthful irritate two kinds of compound samples of extract and compare with the sample of single kind of extract, give the mouse of the sample of composite extract, its serum alt and AST are lower,, but difference not remarkable (seeing table 1 for details).Explain that beverage of the present invention has the effect of protecting and nourishing liver really.
Table 1 is respectively organized mice serum ALT and AST measured value (a ± s)
Annotate: * * representes to compare with control group in the table, and difference is extremely remarkable.
Claims (2)
1. vinegar beverage with function of protecting and nourishing liver; It is characterized in that: form: xylo-oligosaccharide 7～14%, vinegar 15～20%, food and medicine consangunity protecting and nourishing liver active components of plants 8% by following components in weight percentage; Stevioside 0.005～0.02%, surplus are water; Wherein, said food and medicine consangunity protecting and nourishing liver active components of plants is one of following:
1. Lotus Leafextract;
2. Fructus Citri Sarcodactylis extract;
3. capejasmine extract;
4. papaya extractives;
5. papaya extractives and chrysanthemum extract mixes;
6. capejasmine extract and orange peel extract mixes.
2. a kind of vinegar beverage with function of protecting and nourishing liver according to claim 1 is characterized in that: the acidity >=3.5g/100ml of said vinegar.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102312280A CN101716008B (en) | 2009-12-08 | 2009-12-08 | Vinegar beverage with function of protecting and nourishing liver |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102312280A CN101716008B (en) | 2009-12-08 | 2009-12-08 | Vinegar beverage with function of protecting and nourishing liver |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101716008A CN101716008A (en) | 2010-06-02 |
| CN101716008B true CN101716008B (en) | 2012-07-04 |
Family
ID=42430711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102312280A Active CN101716008B (en) | 2009-12-08 | 2009-12-08 | Vinegar beverage with function of protecting and nourishing liver |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101716008B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103494289B (en) * | 2011-01-31 | 2014-11-12 | 徐志强 | Method for producing damp clearing and water retention alleviating vinegar beverage |
| CN103535709B (en) * | 2012-07-09 | 2015-07-01 | 贾洪章 | Healthcare food for chemical liver injury |
| CN104146251B (en) * | 2014-08-05 | 2015-12-30 | 彭婷婷 | Health food |
| CN104172359B (en) * | 2014-09-02 | 2015-08-05 | 王永妍 | Vinegar drink of control cardiovascular and cerebrovascular disease and preparation method thereof |
| CN108403876A (en) * | 2018-05-22 | 2018-08-17 | 长沙曙光医疗科技有限公司 | A kind of liquid medicine and preparation method thereof with liver protecting antialcoholism function |
-
2009
- 2009-12-08 CN CN2009102312280A patent/CN101716008B/en active Active
Non-Patent Citations (2)
| Title |
|---|
| 刘桂芹 等.《双歧养生醋的研制》.《饮料工业》.2006,第9卷(第4期),第20-22页. |
| 刘桂芹 等.《双歧养生醋的研制》.《饮料工业》.2006,第9卷(第4期),第20-22页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101716008A (en) | 2010-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20160087114A (en) | Food additive containing flowers | |
| CN106616823A (en) | Hotpot condiment | |
| CN101716008B (en) | Vinegar beverage with function of protecting and nourishing liver | |
| Khan et al. | Wild edible plants as a food Resource: Traditional Knowledge | |
| CN106616183B (en) | Solid beverage composition with maca and dandelion as main flavor agents and preparation method thereof | |
| CN103416561A (en) | Dahurian patrinia herb tea and starter culture thereof | |
| KR20130133946A (en) | Soybean paste comprising herbal medicine and manufacturing method thereof | |
| Aggarwal et al. | Healing spices: How to use 50 everyday and exotic spices to boost health and beat disease | |
| KR20140027772A (en) | Method manufacture of platycodon grandiflorum tea | |
| Ashok et al. | Nutraceutical values of minor fruits on immunity development to combat diseases | |
| Grogan | Healing spices handbook | |
| Eliseeva et al. | Valerian (lat. Valeriana) | |
| KR101694431B1 (en) | Mixed tea composition of herbal medicine having the improved taste, and preparation thereof | |
| KR20140076260A (en) | Sweet jelly of red beans using a jujube and a method of there of | |
| Mars | Dandelion medicine: remedies and recipes to detoxify, nourish, and stimulate | |
| Bakhru | Indian spices & condiments as natural healers | |
| Ye et al. | Traditional Chinese dates (Jujubes)-based functional foods in Chinese history | |
| CN110771764A (en) | Preparation method of jasmine flower-flavored vinegar beverage | |
| CN101653250A (en) | Preparation method of chrysanthemum healthy tea | |
| KR102636322B1 (en) | Method for manufacturing dried yellow corvina with gochujang and dried yellow corvina with gochujang produced thereby | |
| KR20120109675A (en) | The method for manufacturing of health drink | |
| Hartvig | Healing Spices: 50 Wonderful Spices, and How to Use Them in Health-giving, Immunity-boosting Foods and Drinks | |
| Yampolsky et al. | Basil (lat. Ócimum) | |
| KR20170114400A (en) | Beverage composition with mixture extract of Cynanchum wilfordii, Angelica gigas and concentrate of wild ginseng fruit | |
| Eliseeva et al. | Mandarin (lat. Cītrus reticulāta) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PP01 | Preservation of patent right | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20180312 Granted publication date: 20120704 |
|
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20210312 Granted publication date: 20120704 |
|
| PD01 | Discharge of preservation of patent | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20210312 Granted publication date: 20120704 |
|
| PP01 | Preservation of patent right | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20230307 Granted publication date: 20120704 |
|
| PD01 | Discharge of preservation of patent |